
    
      Approximately 48 subjects aged 5-17 years inclusive will be randomised into the study.

      Subjects with recent onset of presumptive influenza will have influenza A or B infection
      confirm by Rapid Antigen Test.

      The study will be conducted on an outpatient basis. The dose is administered in a single
      session in the clinic on Day 1. The subject will return to the clinic for assessments and
      follow up.
    
  